Skip to main
MRX

MRX Market Capitalization Overview

Market Cap: $2.81B as of Dec 22, 2025

$2.81B
$482.96M (20.78%)past month
As of Dec 22, 2025, MRX has a market capitalization of $2.81B. Over the past 30 days, its market cap has increased by 13.1%, while in the last 12 months, it has increased by 28.13%.

Market capitalization represents the total value of Marex Group PLC as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

MRX Market Cap Formula = Stock Price * Shares Outstanding

The market cap of MRX helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

MRX Market Cap History

DateMarket CapChange
Dec 1, 2025$2.50B+13.10%
Nov 3, 2025$2.21B+1.14%
Oct 1, 2025$2.19B-13.32%
Sep 2, 2025$2.52B-6.68%
Aug 1, 2025$2.70B-3.27%
Jul 1, 2025$2.80B-7.79%
Jun 2, 2025$3.03B-1.28%
May 1, 2025$3.07B+22.23%
Apr 1, 2025$2.51B-1.33%
Mar 3, 2025$2.55B+1.01%
Feb 3, 2025$2.52B+10.09%
Jan 2, 2025$2.29B+12.14%

MRX End of Year Market Cap History

DateMarket CapChange
2025$2.81B+28.13%
2024$2.20B

FAQs About Marex Group PLC (MRX) Market Cap

As of Dec 22, 2025, the market capitalization of MRX is $2.81B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Marex Group PLC’s market capitalization has increased by 20.78%, changing from $2.33B to $2.81B as of Dec 22, 2025.

In the last 3 months, Marex Group PLC’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Marex Group PLC’s market capitalization increased from – in January to $2.20B in December, reflecting a — change.

Marex Group PLC (MRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.